BSE Live
Feb 02, 14:02Prev. Close
277.95
Open Price
276.00
Bid Price (Qty.)
278.40 (94)
Offer Price (Qty.)
278.75 (10)
NSE Live
Feb 02, 14:02Prev. Close
278.00
Open Price
278.00
Bid Price (Qty.)
278.55 (23)
Offer Price (Qty.)
278.65 (13)
Quarterly Results of Fortis Healthcare (in Rs. Cr.) | Sep '22 | Jun '22 | Mar '22 | Dec '21 | Sep '21 | |
Net Sales/Income from operations | 1,607.20 | 1,487.85 | 1,378.10 | 1,466.65 | 1,462.54 | |
Other Operating Income | -- | -- | -- | -- | -- | |
Total Income From Operations | 1,607.20 | 1,487.85 | 1,378.10 | 1,466.65 | 1,462.54 | |
EXPENDITURE | ||||||
Consumption of Raw Materials | -- | -- | -- | -- | -- | |
Purchase of Traded Goods | 364.97 | 346.51 | 332.74 | 333.90 | 339.74 | |
Increase/Decrease in Stocks | -0.07 | 2.65 | -9.58 | -0.27 | 11.10 | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | 268.10 | 255.27 | 237.88 | 251.10 | 235.66 | |
Depreciation | 76.92 | 74.29 | 77.28 | 76.11 | 74.54 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 671.27 | 632.32 | 595.83 | 594.99 | 591.69 | |
P/L Before Other Inc., Int., Excpt. Items & Tax | 226.01 | 176.81 | 143.95 | 210.82 | 209.81 | |
Other Income | 15.53 | 20.70 | 5.99 | 6.69 | 8.02 | |
P/L Before Int., Excpt. Items & Tax | 241.54 | 197.51 | 149.94 | 217.51 | 217.83 | |
Interest | 32.80 | 31.20 | 30.02 | 38.06 | 40.34 | |
P/L Before Exceptional Items & Tax | 208.74 | 166.31 | 119.92 | 179.45 | 177.49 | |
Exceptional Items | 51.60 | -- | 0.20 | 8.39 | 0.30 | |
P/L Before Tax | 260.34 | 166.31 | 120.12 | 187.84 | 177.79 | |
Tax | 49.60 | 42.02 | 39.42 | 51.21 | 51.43 | |
P/L After Tax from Ordinary Activities | 210.74 | 124.29 | 80.70 | 136.63 | 126.36 | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -- | -- | |
Net Profit/(Loss) For the Period | 210.74 | 124.29 | 80.70 | 136.63 | 126.36 | |
Minority Interest | -13.87 | -12.06 | -19.06 | -24.97 | -23.74 | |
Share Of P/L Of Associates | 7.50 | 10.02 | 6.33 | 5.08 | 4.24 | |
Net P/L After M.I & Associates | 204.37 | 122.25 | 67.97 | 116.74 | 106.86 | |
Equity Share Capital | 754.96 | 754.96 | 754.96 | 754.96 | 754.96 | |
Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | 2.71 | 1.62 | 0.90 | 1.55 | 1.42 | |
Diluted EPS | 2.71 | 1.62 | 0.90 | 1.55 | 1.42 | |
EPS After Extra Ordinary | ||||||
Basic EPS. | 2.71 | 1.62 | 0.90 | 1.55 | 1.42 | |
Diluted EPS. | 2.71 | 1.62 | 0.90 | 1.55 | 1.42 | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
12.11.2022
Fortis Health Consolidated September 2022 Net Sales at Rs 1,607.20 crore, up 9.89% Y-o-Y
11.11.2022
Fortis Health Standalone September 2022 Net Sales at Rs 266.06 crore, up 20.46% Y-o-Y
06.08.2022
Fortis Health Consolidated June 2022 Net Sales at Rs 1,487.85 crore, up 5.5% Y-o-Y
06.08.2022
Fortis Health Standalone June 2022 Net Sales at Rs 247.15 crore, up 21.44% Y-o-Y